Laboratory Assistant (f/m/d)
The Interdisciplinary Laboratory (lead by Prof. Jindrich Cinatl; Frankfurt Foundation for Children with Canver) is interested in the underlying mechanism of chemoresistance, overcoming chemoresistance and developing new therapy strategies. To achieve this goal, a unique collecti…
Our foundation presents itself in a new “dress”
The “Frankfurt Foundation for Children with Cancer” was established in 1994 by the association “Hilfe für krebskranke Kinder Frankfurt e. V.”. After more than 25 years in the same guise, the “Frankfurt Foundation for Children with Cancer” now presents itself with a new face of i…
Leifheit Foundation promotes cancer research
Marcus Klüssendorf, Uwe Menger, Dr. Florian Rothweiler, Ingo Nehrbaß
The G. and I. Leifheit Foundation Nassau supports the worldwide unique collection of therapy-resistant cancer cells, the “Resistant Cancer Cell Line Collection” (RCCL-Collection), over three years with a grant…
MAINOVA continues its support
Marcus Klüssendorf, Dr. Constantin H. Alsheimer, Uwe Menger, Dr. Jürgen Vogt
Over the past ten years, Mainova has supported the research of the Frankfurt Foundation for Children with Cancer with a total of around 250,000 euros. Apart from that, the regional energy supplier will…
Prof. Zeuzem on the board of our foundation
As a doctor and scientist, Prof. Zeuzem stands for the close integration of medical research, academic teaching and patient care.
It is a great pleasure for us to be able to continue and expand the successful cooperation between the University of Frankfurt and our Foundation wit…
Easter Campaign 2021 – THANK YOU
A HEARTFELT THANK YOU!
We are overwhelmed by the response we have received to the Easter appeal for donations. Over 20,000 euros have been received on our donation account so far.
This wonderful response from so many people helps us to continue to do everything we can to ensure…
Award of the Maresch-Klingelhöffer Prize
Prof. Jindrich Cinatl, Dr. Constanze Schneider, Dr. Jürgen Vogt
As part of the ceremony to mark the 25th anniversary of the Frankfurt Foundation for Children with Cancer in November 2019, Dr. Constanze Schneider was awarded the Maresch-Klingelhöffer Prize.
The prize has been awa…
New insights into ALL therapy
Mystery of anticancer drug nelarabine for leukaemia treatment solved
Acute lymphoblastic leukaemia (ALL) is the most common cancer in children. With the active substance nelarabine, T-ALL, a subtype that resembles T-lymphocytes, can be treated well. However, B-ALL, a subtype tha…
